Syneron Medical Buying Primaeva Medical
Syneron Medical Ltd. (Nasdaq: ELOS) has agreed to acquire Primaeva Medical Inc., a Pleasanton, Calif.-based developer of a minimally-invasive RF device for the treatment of skin wrinkles and laxity. The deal includes a $7 million up-front payment in cash, plus up to $23 million in earn-out payments. Primaeva Medical had raised around $14 million in VC funding, from Affinity Capital Management, Delphi Ventures and Frazier Healthcare Ventures.
16 October 2009•4 mins read
